Ozempic shortages until December

Diabetes medication shortfall “worse than ever” The long-running shortage of diabetes drug Ozempic (semaglutide) looks set to continue until at least the end of the year, according to a revised joint statement from the TGA and drug sponsor Novo Nordisk. Though broadly the same as the first alert posted back in May, there was one

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pride in ‘altruistic profession’ shines
Next ‘There's a fair degree of trial and error at the moment.’